REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
11/08/2025
Voltar para busca
Dado oficial do USPTO
GC
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Snapshot rápido
ST13
US500000079241700Classe
5, 10, 35, 42, 44
Pedido
79241700
Registro
6121018
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
66
Atualização mais recente
12/08/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 10, 35, 42, 44
Data de depósito
17/05/2018
Data de registro
11/08/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
11/08/2020
Última transação
12/08/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
03
Localização do titular
KR
Examinador
LAWRENCE, SUE
Unidade examinadora
M70
Localização atual
PETITIONS OFFICE
Descrição da marca
The mark consists of a stylized rounded cross with the top and right arms in red fading toward the middle to orange then to yellow, and the left and lower arms in green; to the right of the cross are the letters "GC" in deep blue.
Titulares e representantes
Titulares
Green Cross Holdings Corporation
Representantes
Yoon S. Ham Hauptman Ham, LLP
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Medicines for humans used for the prevention and treatment of cancercerebrovascular thrombosismyocardial infarctionsperipheral artery occlusionspulmonary embolismsthrombocytopeniathrombophlebitisJapanese EncephalitisHepatitis B VirusHepatitis C VirusImmunodeficiency diseaseHuman Immunodeficiency Virusrare diseaseMedicines for humans used for the prevention and treatment of cancercerebrovascular thrombosismyocardial infarctionsperipheral artery occlusionspulmonary embolismsthrombocytopeniathrombophlebitisJapanese EncephalitisHepatitis B VirusHepatitis C VirusImmunodeficiency diseaseHuman Immunodeficiency Virusrare diseaseHunter SyndromeHemophiliaHemophilia Aarthritisosteoarthritisarthritis deformansperiarthritis humeroscapularistendinitisperitendinitishumeral epicondylitisidiopathic thrombocytopenic purpuraGuillain-barre syndromeKawasaki syndromeClostridium tetanivirus infectioninfluenzabacterial infection and chronic pain; Medicines for humansblood plasma-derivativesalbuminsimmunoglobulinsblood clotting factors; medicated plasters; vaccines; biological preparations for medical or veterinary purposesbiological preparations used for the prevention and treatment of cancercerebrovascular thrombosismyocardial infarctionsperipheral artery occlusionspulmonary embolismsthrombocytopeniathrombophlebitisJapanese EncephalitisHepatitis B VirusHepatitis C VirusImmunodeficiency diseaseHuman Immunodeficiency Virusrare diseaseHunter SyndromeHemophiliaHemophilia Aarthritisosteoarthritisarthritis deformansperiarthritis humeroscapularistendinitisperitendinitishumeral epicondylitisidiopathic thrombocytopenic purpuraGuillain-barre syndromeKawasaki syndromeClostridium tetanivirus infectioninfluenzabacterial infection and chronic pain; biological preparations for medical or veterinary purposesblood plasma-derivativesalbuminsimmunoglobulinsblood clotting factors
Classe 10
Medical apparatus and instruments for use in performing biopsies; medical testing apparatus for medical purposesmedical apparatus for testing DNA and RNA samples; medical diagnostic apparatus and instruments for immunodiagnosis and molecular diagnosis; electromedical diagnostic instruments for immunodiagnosis and molecular diagnosis; apparatus for use in medical analysismedical apparatus for blood test; medical health signal measuring instruments for monitoring vital signs; wireless bio-signal measuring instruments for medical purposesbiofeedback sensors; precision sensors for medical useheart rhythm sensorsrespiratory sensors and biofeedback sensors; laser machining tools for medical uselasers for surgical and medical use; genetic testing apparatusapparatus for DNA and RNA testing for medical purposes
Classe 35
Retail store services featuring pharmaceutical preparations for the treatment of cells; retail store services featuring medical instruments; retail store services featuring medical apparatus; retail store services featuring biological preparations for medical purposes; retail store services featuring medical genetic analyzer; retail and wholesale store services featuring pharmaceutical preparations; import-export agency services; retail store services featuring electromedical diagnostic instruments; wholesale store services featuring pharmaceutical preparations for the treatment of cells; wholesale store services featuring medical instruments; wholesale store services featuring medical apparatus; wholesale store services featuring biological preparations for medical purposes; wholesale store services featuring medical genetic analyzer; wholesale store services featuring electromedical diagnostic instruments; all the foregoing excluding services in the field of industrialinstitutionalcommercial and janitorial equipment and supplies
Classe 42
Research and development of vaccines and medicines; conducting clinical studies of medicines for medical research purposes; clinical research in the nature of performing biopsies for medical research; product research and development of medical products; conducting technical project studiesengineering services in the nature of technical project planning and design engineering of medical products; testinginspection or research of pharmaceuticals; scientific research relating to biology; scientific research in the field of genetic engineering; research and development of technology for biotechnology; scientific research in the fields of biomedicine; laboratory research in the field of biology; product development of cell therapy products; drug discovery services; research and development in the pharmaceutical and biotechnology fields; scientific research in the field of gene analysis; medical studiesmedical laboratory services; research and development of technology for medicinal chemical manufacturing; medical research services relating to clinical data
Classe 44
Medical servicesthe removaltreatment and processing of human bloodumbilical cord bloodhuman cellsstem cells and bone marrow for medical preventivediagnostic and treatment purposes; medical examination services; health clinic servicesmedical clinics; analysis of human tissues for medical diagnosis purposes and treatment; medical consultancy for selecting appropriate medicines; human tissue bank services; medical servicesclinical pathology examination; cord blood bank services; health center services; medical and pharmaceutical consultancy; medical and health care services; pharmacy servicesdispensing of pharmaceuticals; consultancy and information services relating to the dispensing of pharmaceutical products; dispensing of pharmaceuticals; preparation and dispensing of medications; information services relating to utilization of medical products in connection with the provision of medical services; medical and health services relating to DNAgenetics and genetic testing; managed health care services
Publicações
Histórico de despachos e eventos da marca no USPTO.
66 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
26/12/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/12/2020
FIMP
FINAL DISPOSITION PROCESSED
03/12/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11/11/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
11/08/2020
GPNX
NOTIFICATION PROCESSED BY IB
12/06/2020
CHPB
POST PUBLICATION AMENDMENT - ENTERED
12/06/2020
APET
ASSIGNED TO PETITION STAFF
11/06/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
26/05/2020
PUBO
PUBLISHED FOR OPPOSITION
26/05/2020
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
11/05/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/05/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/05/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/05/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
21/04/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
13/04/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
13/04/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
13/04/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
13/04/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
13/04/2020
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
02/04/2020
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
20/03/2020
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
10/03/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
04/03/2020
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
04/03/2020
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
26/02/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/02/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
19/02/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
19/02/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
19/02/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
19/02/2020
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
19/02/2020
ISMR
WITHDRAWN FROM ISSUE - MANAGING ATTORNEY REQUEST
19/02/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/01/2020
PUBO
PUBLISHED FOR OPPOSITION
14/01/2020
GPNX
NOTIFICATION PROCESSED BY IB
10/01/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
25/12/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
25/12/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25/12/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/12/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/12/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/12/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
30/07/2019
GNRT
NON-FINAL ACTION E-MAILED
30/07/2019
CNRT
NON-FINAL ACTION WRITTEN
30/07/2019
LOPT
LETTER OF PROTEST EVIDENCE FORWARDED
23/07/2019
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
30/05/2019
GNSL
LETTER OF SUSPENSION E-MAILED
30/05/2019
CNSL
SUSPENSION LETTER WRITTEN
30/05/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/05/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/05/2019
ALIE
ASSIGNED TO LIE
08/05/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/05/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22/04/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22/04/2019
RFNT
REFUSAL PROCESSED BY IB
24/11/2018
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
02/11/2018
RFRR
REFUSAL PROCESSED BY MPU
02/11/2018
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
19/10/2018
CNRT
NON-FINAL ACTION WRITTEN
18/10/2018
MAFR
APPLICATION FILING RECEIPT MAILED
13/10/2018
DOCK
ASSIGNED TO EXAMINER
09/10/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/10/2018
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
27/09/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace GC ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.